Perrem L[au] - Search Results

Year	Number of Results
2012	1
2015	1
2016	2
2017	1
2018	1
2019	6
2020	4
2021	4
2022	6
2023	0

1

Apples to apples? Comparative analyses of national CF registries.

Perrem LM, McNally P, Ratjen F. Perrem LM, et al. Thorax. 2022 Feb;77(2):112-113. doi: 10.1136/thoraxjnl-2021-217532. Epub 2021 Aug 19. Thorax. 2022. PMID: 34413164 No abstract available.

2

Moving the dial on identifying endotypes of asthma from early life.

Perrem L, Subbarao P. Perrem L, et al. Eur Respir J. 2022 Sep 29;60(3):2201031. doi: 10.1183/13993003.01031-2022. Print 2022 Sep. Eur Respir J. 2022. PMID: 36175027 No abstract available.

3

Routine clinical monitoring fails to identify children at high risk of lung function decline.

Perrem L. Perrem L. J Cyst Fibros. 2022 Nov;21(6):904-905. doi: 10.1016/j.jcf.2022.08.017. Epub 2022 Aug 30. J Cyst Fibros. 2022. PMID: 36050145 No abstract available.

4

Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis.

Perrem L, Ratjen F. Perrem L, et al. Front Pharmacol. 2020 Sep 11;11:576293. doi: 10.3389/fphar.2020.576293. eCollection 2020. Front Pharmacol. 2020. PMID: 33013419 Free PMC article. Review.

5

The remaining barriers to normalcy in CF: Advances in assessment of CF lung disease.

Muston HN, Perrem L, Davis MD, Ratjen F, Ren CL. Muston HN, et al. Among authors: perrem l. Pediatr Pulmonol. 2021 Feb;56 Suppl 1:S90-S96. doi: 10.1002/ppul.24929. Pediatr Pulmonol. 2021. PMID: 32589821 Review.

6

How to use noninvasive positive airway pressure device data reports to guide clinical care.

Perrem L, Mehta K, Syed F, Baker A, Amin R. Perrem L, et al. Pediatr Pulmonol. 2020 Jan;55(1):58-67. doi: 10.1002/ppul.24555. Epub 2019 Oct 31. Pediatr Pulmonol. 2020. PMID: 31671252 Review.

7

Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators.

Perrem L, Ratjen F. Perrem L, et al. Pediatr Pulmonol. 2019 Nov;54 Suppl 3:S46-S55. doi: 10.1002/ppul.24364. Pediatr Pulmonol. 2019. PMID: 31715088 Review.

8

Development and Validation of an Algorithm for Quality Grading of Pediatric Spirometry: A Quality Improvement Initiative.

Perrem L, Wilson D, Dell SD, Ratjen F. Perrem L, et al. Ann Am Thorac Soc. 2022 Jan;19(1):74-81. doi: 10.1513/AnnalsATS.202103-382QI. Ann Am Thorac Soc. 2022. PMID: 34343027 Review.

9

The lung clearance index as a monitoring tool in cystic fibrosis: ready for the clinic?

Perrem L, Rayment JH, Ratjen F. Perrem L, et al. Curr Opin Pulm Med. 2018 Nov;24(6):579-585. doi: 10.1097/MCP.0000000000000515. Curr Opin Pulm Med. 2018. PMID: 30095491 Review.

10

Statins versus placebo for people with chronic obstructive pulmonary disease.

Walsh A, Perrem L, Khashan AS, Henry MT, Ni Chroinin M. Walsh A, et al. Among authors: perrem l. Cochrane Database Syst Rev. 2019 Jul 31;7(7):CD011959. doi: 10.1002/14651858.CD011959.pub2. Cochrane Database Syst Rev. 2019. PMID: 31425628 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results